Dennis J. Carlo PhD - 25 May 2022 Form 4 Insider Report for Adamis Pharmaceuticals Corp

Role
Former President & CEO
Signature
/s/ David C. Benedicto, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 16:07:12 UTC
Previous filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMP Common Stock Options Exercise +250,000 +87% 535,867 25 May 2022 Direct F1
holding ADMP Common Stock 150,709 25 May 2022 By Dennis and Allison Carlo Joint Living Trust
holding ADMP Common Stock 5,883 25 May 2022 By A.Carlo as custodian for Child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMP Restricted Stock Units Options Exercise $0 -250,000 -100% $0.000000* 0 25 May 2022 Common Stock 250,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dennis J. Carlo PhD is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs.
F2 On March 1, 2017, the reporting person was granted 250,000 Restricted Stock Units. On May 25, 2022 all of these Restricted Stock Units were fully vested.